Michael Eisenstein
Freelance Writer
Nature
From this contributor
Treatments: In the waiting room
After years of making do with drugs developed for other conditions, doctors and scientists are eagerly pursuing drugs that target the social symptoms of autism.
Explore more from The Transmitter
Neuroscientists reeling from past cuts advocate for more BRAIN Initiative funding
The director of the U.S. National Institutes of Health calls BRAIN a “high priority” but acknowledges that difficult decisions lie ahead if federal budgets remain flat.
Neuroscientists reeling from past cuts advocate for more BRAIN Initiative funding
The director of the U.S. National Institutes of Health calls BRAIN a “high priority” but acknowledges that difficult decisions lie ahead if federal budgets remain flat.
‘Huge influx’ of neuroscientists migrates to Bluesky
Daily neuroscience-related posts on the social-media platform this week have increased more than 400 percent, on average, compared with October.
‘Huge influx’ of neuroscientists migrates to Bluesky
Daily neuroscience-related posts on the social-media platform this week have increased more than 400 percent, on average, compared with October.
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.